Seer (SEER) Change in Acquisitions & Divestments (2020 - 2026)
Seer (SEER) posted quarterly Change in Acquisitions & Divestments of $68.3 million for Q1 2026, down 22.1% year-over-year from $87.6 million in Q1 2025, and up 67.98% quarter-over-quarter from $40.6 million in Q4 2025.
Seer (SEER) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Seer's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $68.3 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 22.1% year-over-year to $68.3 million; the TTM figure through Mar 2026 stood at $218.4 million (down 26.01% YoY), while the FY2025 annual figure was $237.8 million, down 30.47% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $68.3 million, up from $40.6 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $165.8 million in Q4 2022, with the low at $24.0 million in Q2 2022.
- The 5-year median for Change in Acquisitions & Divestments is $68.5 million (2024), against an average of $84.2 million.
- The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments surged 590.76% in 2022, then sank 62.61% in 2024.
- Seer's Change in Acquisitions & Divestments stood at $165.8 million in 2022, then tumbled by 43.91% to $93.0 million in 2023, then retreated by 26.15% to $68.7 million in 2024, then slumped by 40.84% to $40.6 million in 2025, then surged by 67.98% to $68.3 million in 2026.
- Business Quant data shows SEER's Change in Acquisitions & Divestments at $68.3 million in Q1 2026, $40.6 million in Q4 2025, and $64.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.33 Mn |
| Jun 30, 2026 | 18.33 Mn |
| Mar 31, 2026 | 68.26 Mn |
| Mar 31, 2026 | 68.26 Mn |
| Dec 31, 2025 | 40.63 Mn |
| Dec 31, 2025 | 40.63 Mn |
| Sep 30, 2025 | 64.22 Mn |
| Sep 30, 2025 | 64.22 Mn |
| Jun 30, 2025 | 45.34 Mn |
| Jun 30, 2025 | 45.34 Mn |
| Mar 31, 2025 | 87.63 Mn |
| Mar 31, 2025 | 87.63 Mn |
| Dec 31, 2024 | 68.68 Mn |
| Dec 31, 2024 | 68.68 Mn |
| Sep 30, 2024 | 79.32 Mn |
| Sep 30, 2024 | 79.32 Mn |
| Jun 30, 2024 | 59.62 Mn |
| Jun 30, 2024 | 59.62 Mn |
| Mar 31, 2024 | 134.41 Mn |
| Mar 31, 2024 | 134.41 Mn |